Pfizer & BioNTech Share Results on Boosters a...

Andreas Steno and Mikkel Rosenvold are back to challenge one of the biggest narratives in markets: that the AI boom is simply another dot-com bubble waiting to burst. They break down why today's AI investment cycle may be fundamentally different from the late 1990s, and what that ...  Show more

Ash Bennington sits down with Jonathan Gould, U.S. Comptroller of the Currency, to break down the OCC’s final rule implementing its portion of the GENIUS Act. Gould explains how the new federal framework will regulate payment stablecoin issuers, including reserve requirements, re ...  Show more

Carl Quintanilla and Jim Cramer begin the morning discussing Pfizer’s announcement that its experimental COVID-19 pill reduces the risk of death and hospitalization by 89%. Shares of Pfizer surging on the news. Plus, job creation roaring back in October as payrolls rose by 531,0 ...  Show more

Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no ser ...

The morning after the best day for both the S&P 500 and Nasdaq since March, Carl Quintanilla, Jim Cramer and David Faber led off the show with news out of Pfizer and BioNTech: Data shows their COVID-19 vaccine neutralized the omicron variant with three shots. The anchors discusse ...  Show more